| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |